Tristel PLC
LSE:TSTL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
350
500
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TSTL stock under the Base Case scenario is 428.42 GBX. Compared to the current market price of 440 GBX, Tristel PLC is Overvalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Tristel PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for TSTL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Tristel PLC
Balance Sheet Decomposition
Tristel PLC
Current Assets | 22.1m |
Cash & Short-Term Investments | 10.8m |
Receivables | 6.9m |
Other Current Assets | 4.5m |
Non-Current Assets | 18.7m |
PP&E | 8.4m |
Intangibles | 9.7m |
Other Non-Current Assets | 626k |
Current Liabilities | 4.5m |
Accounts Payable | 3.7m |
Other Current Liabilities | 814k |
Non-Current Liabilities | 5.2m |
Long-Term Debt | 5.1m |
Other Non-Current Liabilities | 48k |
Earnings Waterfall
Tristel PLC
Revenue
|
39.5m
GBP
|
Cost of Revenue
|
-6.9m
GBP
|
Gross Profit
|
32.6m
GBP
|
Operating Expenses
|
-26.4m
GBP
|
Operating Income
|
6.2m
GBP
|
Other Expenses
|
-139k
GBP
|
Net Income
|
6m
GBP
|
Free Cash Flow Analysis
Tristel PLC
GBP | |
Free Cash Flow | GBP |
TSTL Profitability Score
Profitability Due Diligence
Tristel PLC's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Tristel PLC's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
TSTL Solvency Score
Solvency Due Diligence
Tristel PLC's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Score
Tristel PLC's solvency score is 95/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TSTL Price Targets Summary
Tristel PLC
According to Wall Street analysts, the average 1-year price target for TSTL is 465.73 GBX with a low forecast of 363.6 GBX and a high forecast of 551.25 GBX.
Dividends
Current shareholder yield for TSTL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 189 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. The company markets its products under the Tristel, Anistel, and Crystel brands.
Contact
IPO
Employees
Officers
The intrinsic value of one TSTL stock under the Base Case scenario is 428.42 GBX.
Compared to the current market price of 440 GBX, Tristel PLC is Overvalued by 3%.